Immune to Cancer: The CRI Blog

The body’s ability to produce protective antibodies depends on plasma cells, which usually develop from B cells…

Hepatocellular carcinoma (HCC) remains one of the deadliest cancers worldwide, with limited response rates to current T-cell-boosting…

Long-lasting immune memory is essential for protecting the body against recurring infections and sustaining the effectiveness of…

Why do some patients respond to immunotherapy while others do not? One promising piece of the puzzle…

T cells rely on finely tuned signaling pathways to remain both vigilant and restrained – strong enough…

Interferons (IFNs) are powerful immune molecules, but their use in cancer treatment remains a double-edged sword. While…

While most cancers are caused by a combination of genetic and environmental factors, cancers caused by viruses…

CAR T-cell therapies have transformed cancer treatment, but each treatment is custom-built from a patient’s own cells,…

Some viruses do more than make us sick: they can rewire our cells in ways that lead…